463 related articles for article (PubMed ID: 37619529)
1. Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease.
Sumida K; Pierre JF; Yuzefpolskaya M; Colombo PC; Demmer RT; Kovesdy CP
Semin Nephrol; 2023 Mar; 43(2):151408. PubMed ID: 37619529
[TBL] [Abstract][Full Text] [Related]
2. Microbiome modulation as a novel therapeutic approach in chronic kidney disease.
Sumida K; Lau WL; Kovesdy CP; Kalantar-Zadeh K; Kalantar-Zadeh K
Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):75-84. PubMed ID: 33148949
[TBL] [Abstract][Full Text] [Related]
3. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
[TBL] [Abstract][Full Text] [Related]
4. POTENTIAL THERAPEUTIC OPTIONS TARGETING THE GUT DYSBIOSIS IN CHRONIC KIDNEY DISEASE.
Dobrek Ł
Wiad Lek; 2022; 75(7):1757-1764. PubMed ID: 35962694
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
[TBL] [Abstract][Full Text] [Related]
6. Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
McFarlane C; Ramos CI; Johnson DW; Campbell KL
J Ren Nutr; 2019 May; 29(3):209-220. PubMed ID: 30366767
[TBL] [Abstract][Full Text] [Related]
7. Microbiome modulation to correct uremic toxins and to preserve kidney functions.
Caggiano G; Cosola C; Di Leo V; Gesualdo M; Gesualdo L
Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):49-56. PubMed ID: 31725010
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?
Cavalcanti Neto MP; Aquino JS; Romão da Silva LF; de Oliveira Silva R; Guimarães KSL; de Oliveira Y; de Souza EL; Magnani M; Vidal H; de Brito Alves JL
Pharmacol Res; 2018 Apr; 130():152-163. PubMed ID: 29410236
[TBL] [Abstract][Full Text] [Related]
9. Microbiota issue in CKD: how promising are gut-targeted approaches?
Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
[TBL] [Abstract][Full Text] [Related]
10. Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
Hsu CN; Tain YL
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409313
[TBL] [Abstract][Full Text] [Related]
11. The clinical impact of gut microbiota in chronic kidney disease.
Kim SM; Song IH
Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Preventive and Therapeutic Mechanisms of Probiotics in Chronic Kidney Disease through the Gut-Kidney Axis.
Huang HW; Chen MJ
J Agric Food Chem; 2024 Apr; 72(15):8347-8364. PubMed ID: 38571475
[TBL] [Abstract][Full Text] [Related]
13. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism.
Lambert K; Rinninella E; Biruete A; Sumida K; Stanford J; Raoul P; Mele MC; Wang AY; Mafra D
J Ren Nutr; 2023 Nov; 33(6S):S30-S39. PubMed ID: 37632511
[TBL] [Abstract][Full Text] [Related]
15. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
Li F; Wang M; Wang J; Li R; Zhang Y
Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
[TBL] [Abstract][Full Text] [Related]
16. Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease.
Mafra D; Borges N; Alvarenga L; Esgalhado M; Cardozo L; Lindholm B; Stenvinkel P
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30818761
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis of Gut Microbiota Contributes to Uremic Cardiomyopathy via Induction of IFNγ-Producing CD4
Han B; Zhang X; Wang L; Yuan W
Microbiol Spectr; 2023 Feb; 11(1):e0310122. PubMed ID: 36788674
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
20. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
